ISAPP Publications

Publications

The following are papers that have been published about ISAPP, commissioned by ISAPP or produced as the output from ISAPP meetings or other ISAPP initiatives.

Reid G, Abrahamsson T, Bailey M, Bindels LB, Bubnov R, Ganguli K, Martoni C, O’Neill C, Savignac H, Stanton C, Ship N, Surette M, Tuohy K, van Hemert S. How do probiotics and prebiotics function at distant sites? Beneficial Microbes. In Press.

O’Toole PW, Marchesi JR, Hill C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol. 2017 Apr 25;2:17057.

Reid G, Kumar H, Khan AI, Rautava S, Tobin J, Salminen S. The case in favour of probiotics before, during and after pregnancy: insights from the first 1500 days. Benef Microbes. 2016. 7(3):353-62.

Marco ML, Heeney D, Binda S, Cifelli CJ, Cotter PD, Foligne B, Ganzle M, Kort R, Pasin G, Pihlanto A, Smid EJ, Hutkins R. Health benefits of fermented foods: microbiota and beyond. Current Opinion in Biotechnology 2017, 44:94–102.

Sanders ME, Merenstein DJ, Ouwehand AC, Reid G, Salminen S, Cabana MD, Paraskevakos G, Leyer G. 2016. Probiotic Use in At-Risk Populations. J Amer Pharmacy Assoc. 56:680-686.

Hill C, Scott K, Klaenhammer TR, Quigley E, Sanders ME. 2016. Commentary: Probiotic nomenclature matters. Gut Microbes 7:1-2.

Quigley EMM. 2016. Leaky gut – concept or clinical entity? Curr Opin Gastroenterol 32:74-79.

Reid G, Kumar H, Khan AI, Rautava S, Tobin J, Salminen S. 2016. The case in favour of probiotics before, during and after pregnancy: insights from the first 1500 days. Beneficial Microbes. Feb 3:1-10.

Sanders ME, Shane AL, Merenstein DJ. Advancing Probiotic Research in Humans the United States: Challenges and strategies. Gut Microbes 7(2):97-100.

Hutkins RW, Krumbeck JA, Bindels LB, Cani PD, Fahey G, Goh YH, Hamaker B, Martens EC, Mills DA, Rastal RA, Vaughan E, Sanders ME. 2016 Prebiotics: why definitions matter. Curr Opinion Biotechnol. 37:1–7.

Kumar H, Salminen S, Vergagen H, Rowland I, Heimbach J, Banares S, Young T, Nomoto K, Lalonde M. 2015. Novel probiotics and prebiotics: road to the market. Curr Opinion Biotechnol. 32:99-103.

Sung V, Cabana MD, D’Amico F, Deshpande G, Dupont C, Indrio F, Mentula S, Partty A, Savino F, Szajewska H, Tancredi D. 2014. Lactobacillus reuteri DSM17938 for managing infant colic: protocol for an individual participant data meta-analysis. BMJ Open:e006475. doi:10.1136/bmjopen-2014-006475, (Protocol also registered in PROSPERO database)

Reid G, Brigidi P, Burton JP, Contractor N, Duncan S, Fargier E, Hill C, Lebeer S, Martin R, McBain AJ, Mor G, O’Neill C, Rodriguez JM, Swann J, vanHemert S, Ansell J. 2014. Microbes central to human reproduction. Amer J Reproductive Immunol. Sep 24. doi: 10.1111/aji.12319.

Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. 2014. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Rev Gastroenterol Hepatol 11, 506-514.

Sanders ME, Klaenhammer TR, Ouwehand AC, Pot B, Johansen E, Heimbach JT, Marco ML, Tennilä J, Ross RP, Franz C, Pagé N, Pridmore RD, Leyer G, Salminen S, Charbonneau D, Call E, Lenoir-Wijnkoop I. 2014. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Annals of the New York Academy of Sciences 1309:1-18.

Sanders ME, Lenoir-Wijnkoop I, Salminen S, Merenstein D, Pot B, Petschow BW, Nieuwdorp. M, Tancredi D, Cifelli D, Jacques P, Gibson G. 2014. Probiotics and Prebiotics: Prospects for Public Health and Nutritional Recommendations. Annals NY Acad Sci 1309:19-29.

Sheridan PO, Bindels L, Saulnier DM, Reid G, Nova E, Holmgren K, O’Toole PW, Bunn J, Delzenne N, Scott KP. 2013. Can prebiotics and probiotics improve therapeutic outcomes for undernourished individuals? Gut Microbes 5(1):1-9.

Blatchford P, Ansell J, Godoy, MRC, Fahey G, Garcia-Mazcorro JF, Gibson GR, Goh. YJ, Hotchkiss AT, Hutkins R, LaCroix C, Rastall RA, Reimer R, Schoterman M, Van. Sinderen D, Venema K, Whelan K. 2013. Prebiotic mechanisms, functions and applications – A review. Int J Probiotics Prebiotics 8:109-132.

Petschow B. Doré J, Hibberd P, Dinan T, Reid G, Blaser M, Cani P, Degnan, F, Foster J, Gibson G, Hutton J, Klaenhammer TR, Ley R, Nieuwdorp M, Pot B, Relman. D, Serazin A and Sanders ME. 2013. Probiotics, prebiotics, and the host microbiome: the science of translation. Annals of the New York Academy of Sciences 1306:1-17.

Shane AL, Deshpande GC, Merenstein D.
Improved neonatal outcomes with probiotics. JAMA Pediatr. 2013; 167:885-6.

Saulnier DM, Ringel Y, Heyman MB, Foster JA, Bercik P, Shulman RJ, Versalovic J, Verdu E, Dinan TG, Hecht G, Guarner F. 2013. The Intestinal Microbiome, Probiotics, and Prebiotics in Neurogastroenterology. Gut Microbes 4:17-27.

Degnan, F. 2012. Clinical studies involving probiotics. When FDA’s investigational new drug rubric applies—and when it may not. Gut Microbes 3:485-489. And related letter to the editor.

Hill, C. Virulence or niche factors; what’s in a name? 2012. J Bacteriol. 194(21):5725-7.

Macklaim JM, Cohen CR, Donders G, Gloor GB, Hill JE, Parham GP, Ravel J, Spear G, van de Wijgert J, Reid G. Exploring a Road Map to Counter Misconceptions About the Cervicovaginal Microbiome and Disease. Reprod Sci. 2012; 19:1154-62

Sanders ME, Heimbach JT, Pot B, Tancredi D, Lenoir-Wijnkoop I, Lähteenmäki-Uutela A, Gueimonde M, Bañares S. 2011. Health claims substantiation for probiotic and prebiotic products. Gut Microbes 2 (3): 127-133.

Monachese M, Cunningham-Rundles S, Diaz MA, Ermond E, Guerrant R, Hummelen R, Kemperman R, Kerac M, Kort R, Merenstein D, Panigrahi P, Ramakrishna B, Safdar N, Shane A, Trois L, Reid G. 2011. Probiotics and prebiotics to combat enteric diarrheal diseases and HIV in the developing world: a consensus report. Gut Microbes 2:198-207.

Champagne CP, Ross RP, Saarela M, Hansen KF, Charalampopoulos D. Recommendations for the viability assessment of probiotics as concentrated cultures
and in food matrices. Appl Environ Microbiol. Int J Food Microbiol. 2011 Oct 3;149(3):185-93.

Guarner F, Sanders ME, Gibson G, Klaenhammer T, Cabana M, Scott K, Reid G, Delzenne N, Fahey G, Hill C. 2011. Probiotic and prebiotic claims in Europe: seeking a clear roadmap. Br J Nutr. 106:1765-1767.

Wallace TC, Guarner F, Madsen K, Cabana M, Gibson G, Hentges E, Sanders ME. 2011. Human Gut Microbiota and Their Relationship to Health and Disease. Nutrition Reviews 69:392-403.

Sanders ME, Heimbach JT, Pot B, Tancredi D, Lenoir-Wijnkoop I, Lähteenmäki-Uutela A, Gueimonde M, Bañares S. 2011. Health claims substantiation for probiotic and prebiotic products. Gut Microbes 2:1-7.

Monachese M, Cunningham-Rundles S, Diaz MA, Ermond E, Guerrant R, Hummelen R, Kemperman R, Kerac M, Kort R, Merenstein D, Panigrahi P, Ramakrishna B, Safdar N, Shane A, Trois L, Reid G. 2011. Probiotics and prebiotics to combat enteric diarrheal diseases and HIV in the developing world: a consensus report. Gut Microbes 2:198-207.

O’Flaherty S, Saulnier D, Pot B, Versalovic J. How can probiotics and prebiotics impact mucosal immunity? Gut Microbes 2010; 1(5): 293-300.

Reid G. 2010. The media and probiotics: provocation or dialogue? International Journal of Probiotics and Prebiotics 5(4):165-168.

Sanders ME. 2010. International Scientific Association for Probiotics and Prebiotics 2010 Meeting Report. Functional Food Reviews 2:131-140.

Reid G. 2010. Putting science first – The International Scientific Association for Probiotics and Prebiotics (ISAPP). Functional Food Reviews. 2:124-130.

Shane AL, Cabana M, Vidry S, Merenstein D, Hummelen R, Ellis CL, Heimbach JT, Hempel S, Lynch S, Sanders ME, Tancredi DJ. 2010. Guide to designing, conducting, publishing, and communicating results of clinical studies involving probiotic applications in human participants. Gut Microbes 1:243-253.

Gibson GR, Scott KP, Rastall RA, Tuohy KM, Hotchkiss A, Dubert-Ferrandon A, Gareau M, Murphy EF, Saulnier D, Loh G, Macfarlane S, Delzenne N, Ringel Y, Kozianowski G, Dickmann R, Lenoir-Wijnkoop I, Walker C, Buddington R. 2010. Dietary prebiotics: Current status and new definition. IFIS Functional Foods Bulletin 7(1):1–19.

Reid G, Gaudier E, Guarner F, Huffnagle GB, Macklaim J, Munoz AM, Martini M, Ringel-Kulka T, Sartor B, Unal R, Verbeke K, Walter J. 2010. Responders and non-responders to probiotic interventions: how can we improve the odds? Gut Microbes 1(3):1-5.

Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Huys G, Levy D, Mack D, Phothirath P, Constable A, Solano-Aguilar G, Vaughan E. 2010. Safety assessment of probiotics for human use. Gut Microbes 1 (3):1-22.

Delzenne N, Reid G. No causal link between obesity and probiotics. Nat Rev Microbiol. 2009 Dec;7(12):901

Reid G, Gibson G, Sanders ME, Guarner F, Versalovic J. 2008. Probiotic prophylaxis in predicted severe acute pancreatitis. The Lancet 372:112-113.

Reid, G. 2008. Probiotics and prebiotics – Progress and challenges. International Dairy Journal, 18:969–975.

Sanders ME, Hamilton-Miller, J, Reid G, Gibson G. 2007. A nonviable preparation of L. acidophilus is not a probiotic. Clin Infect. Dis. 44:886.

Lenoir-Wijnkoop I, Sanders, M.E., Van Loo, J., Rayes, N., Timmerman, H., Sherman, P. Cabana, M., Corthier, G., Charbonneau, D., Vaneechoutte, M., Caglar, E., Wolvers, D., Manneck, I. 2007. Probiotic and prebiotic influence beyond the intestinal tract. Nutr Rev. 65:469-489.

Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA. 2006. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 3(5):275-84.

Reid G, Gibson GR, Gill HS, Klaenhammer TR, Rastall RA, Rowland I Sanders ME. 2006. Use of genetically modified microbes for human health. Microbial Ecol. Health Dis. 18: 75-76.

Reid G, Anand S, Bingham MO, Mbugua G, Wadstrom T, Fuller R, Anukam K Katsivo M. 2005. Probiotics for the developing world. J Clin Gastroenterol. 39(6):485-8.

Sanders ME, Guarner F, Mills D, Pot B, Rafter J, Rastall R, Reid G, Ringel Y, Rowland I, Saarela M, Tuohy K. 2005. Selected topics in probiotics and prebiotics: meeting report for the 2004 International Scientific Association for Probiotics and Prebiotics. Cur Iss Intestinal Microbiol. 6: 55-68.

Rastall R, Gibson G, Gill H, Guarner F, Klaenhammer T, Pot B, Reid G, Rowland I, Sanders ME. 2005. Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. FEMS Microbial Ecology 52(2): 145-152.

Sanders ME, Tompkins T, Heimbach J, Kolida S. 2005. Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: scientific and regulatory considerations in Canada, EU, and U.S. Eur J Nutr. 44(5):303-10.

Sanders ME. 2005. Objectives and activities of the International Scientific Association for Probiotics and Prebiotics. In, Cesare Schiavi (Ed.) Probiotics, Biotherapeutics & Health. Mofin Alce, Novara, Italy., p. 206-216.

Reid G, Guarner F, Gibson G, Tompkins T, Gill H, Rowland I, Rastall B, Pot B, Sanders ME. 2004. Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 127:366-7.

Mack D. 2004. D(-)-lactic acid producing probiotics, d(-)-lactic acidosis and infants. Canadian J Gastroenterol. 18:671-5.

Tompkins TA, Sanders ME. 2004. Good intentions, poor study design. Can Fam Physician. 50:1499-500.

Reid G., Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer T R. 2003. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol. 37:105-118.

Credibility for probiotics. ISAPP supports research investigating beneficial microorganisms. California Dairy Dispatch. Vol. 12(2), Fall 2002. PDF.

Ferber D. 2002. Much ferment on the probiotics front. ASM News. 68:369-370. PDF